The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Imodium LiquiRelief 2mg Soft Capsules

Johnson & Johnson (Ireland) LimitedPA0330/045/003

Main Information

Trade NameImodium LiquiRelief 2mg Soft Capsules
Active SubstancesLoperamide hydrochloride
Dosage FormCapsule, soft
Licence HolderJohnson & Johnson (Ireland) Limited
Licence NumberPA0330/045/003

Group Information

ATC CodeA07DA Antipropulsives
A07DA03 loperamide


License statusAuthorised
Licence Issued01/04/2011
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back